study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MSK-BOSW-INFL_01,2013,randomized controlled trial,SMD,0.3335,0.2048,0.4622,60,57,low,10.1234/boswellia-msk-bosw-infl-01,musculoskeletal_journal,osteoarthritis_pain,Adults with osteoarthritis pain concerns,None reported,11
MSK-BOSW-INFL_02,2014,randomized controlled trial,SMD,0.3288,0.178,0.4796,71,72,low,10.1234/boswellia-msk-bosw-infl-02,musculoskeletal_journal,osteoarthritis_pain,Adults with osteoarthritis pain concerns,Transient headache,11
MSK-BOSW-INFL_03,2015,randomized controlled trial,SMD,0.2699,0.1061,0.4337,71,72,mixed,10.1234/boswellia-msk-bosw-infl-03,musculoskeletal_journal,osteoarthritis_pain,Adults with osteoarthritis pain concerns,Transient headache,9
